Jane Street’s Apyx Medical APYX Stock Holding History

Jane Street’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$408K	Sell	90,771 -40,526	-31%	-$161K	﹤0.01%	8504
2026 Q1	$484K	Sell	131,297 -36,941	-22%	-$138K	﹤0.01%	8122
2025 Q4	$589K	Buy	+168,238	New	+$587K	﹤0.01%	7320
2024 Q1	–	Sell	-28,050	Closed	-$73.5K	–	9133
2023 Q4	$73.5K	Buy	+28,050	New	+$67.9K	﹤0.01%	8685
2023 Q3	–	Sell	-12,745	Closed	-$64.1K	–	8574
2023 Q2	$64.1K	Buy	+12,745	New	+$64.6K	﹤0.01%	8152
2021 Q4	–	Sell	-11,554	Closed	-$160K	–	10007
2021 Q3	$160K	Sell	11,554 -20,066	-63%	-$211K	﹤0.01%	9018
2021 Q2	$326K	Buy	+31,620	New	+$313K	﹤0.01%	8005

Other funds holding APYX

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street's APYX Position: Q2 2026 in Review

Jane Street reduced its Apyx Medical (APYX) stake by 31% in Q2 2026, selling an estimated $161K and leaving 90,771 shares worth $408K. The position accounts for ﹤0.01% of the portfolio, ranked #8504.

Jane Street first reported a position in APYX in Q2 2021 and has held it in 7 quarters since. The position peaked at $589K in Q4 2025. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

Jane Street held 90,771 shares of Apyx Medical worth $408K as of Q2 2026.
Jane Street sold 40,526 Apyx Medical shares in Q2 2026, an estimated $161K.
Apyx Medical made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8504 holding.
Jane Street first reported a position in Apyx Medical in Q2 2021 and has held it in 7 quarters since.
Jane Street's Apyx Medical position peaked at $589K in Q4 2025.
68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.